Novo Nordisk offers more than 20 medicines for diabetes, chronic weight management, rare bleeding disorders, hormone-related growth disorders and women’s health.

Overview of Novo Nordisk pharmaceutical products within diabetes, obesity, haemophilia, human growth hormone and hormone replacement therapy.

View a list of Novo Nordisk's current diabetes products along with prescribing information and links to their individual product sites for patients and physicians.

Find information about Novo Nordisk medications and devices used to treat diabetes, including insulin and non-insulin medicines.

View our broad range of disposable pre-filled pens, durable pens with replaceable insulin cartridges and smart connected pens for diabetes treatment that meets your needs. * in the US approved under the brand name Xultophy® 100/3.6. ** in the US called NovoLog®. *** in the US spelled Novoeight®. **** in the US approved under the name of REBINYN®.

Find cost and coverage information to save on Novo Nordisk diabetes medicines, including insulins and GLP-1 RAs.

Learn about the different types of insulin, including short-acting, intermediate-acting, and premixed. Find out how each type works to treat type 2 diabetes.

Injection pens and injection needles from Novo Nordisk for diabetes, obesity and growth hormone deficiency. See the types of insulin pens available here and learn how to use our insulin pens.

What is NovoLog ® Mix 70/30? NovoLog ® Mix 70/30 (insulin aspart protamine and insulin aspart) injectable suspension 100 U/mL is a man-made insulin used to control high blood sugar in people with diabetes mellitus. It is not known if NovoLog ® Mix 70/30 is safe and effective in children.

Access information and resources on Novo Nordisk products available to treat Diabetes, Obesity, Growth Hormone Disorders, Hemophilia & Rare Bleeding Disorders.